MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales and maturities
of marketable...
$318,022K
Proceeds from sales of
class a ordinary...
$24,247K
Exercise of stock options
$1,348K
Proceeds from sale of
facility
$18,215K
Net cash flows
provided by (used in)...
$103,965K
Net cash flows
provided by (used in)...
$25,569K
Canceled cashflow
$232,272K
Canceled cashflow
$26K
Net change in cash
and cash...
$9,417K
Canceled cashflow
$120,117K
Purchases of marketable
securities
$217,076K
Purchase of equipment and
facility expansion
$15,196K
Equity-based compensation
$25,336K
Depreciation and
amortization
$6,575K
Prepaid and other assets
-$6,236K
Loss on disposal of
equipment
-$1,431K
Interest receivable
-$1,320K
Impairment charges
$318K
Payments on finance
leases
$26K
Net cash flows used
in operating...
-$120,117K
Canceled cashflow
$41,216K
Net loss before
noncontrolling interest
-$151,612K
Accounts payable and
accrued expenses
-$5,919K
Gain on marketable
securities, net
$3,417K
Income taxes payable
-$356K
Gain on lease
disposition
$29K
Back
Back
Cash Flow
source: myfinsight.com
PROKIDNEY CORP. (PROK)
PROKIDNEY CORP. (PROK)